Datadog's fair value estimate has been trimmed slightly from about US$211.97 to about US$208.49 per share, even as its ...
From tax revenues to the shekel to consumption to real estate, the wave of high-value technology company sales has ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced preliminary, unaudited results for the quarter and full year ended December 31, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback